- Report
- June 2024
- 200 Pages
Global
From €7132EUR$7,950USD£6,101GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,535GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1121EUR$1,250USD£959GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1346EUR$1,500USD£1,151GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1794EUR$2,000USD£1,535GBP
- Drug Pipelines
- April 2025
- 50 Pages
Global
From €1346EUR$1,500USD£1,151GBP
- Report
- June 2025
- 200 Pages
Global
From €2502EUR$2,789USD£2,140GBP
- Report
- July 2025
- 350 Pages
Global
From €4440EUR$4,949USD£3,798GBP
- Report
- July 2024
- 162 Pages
Africa
From €2243EUR$2,500USD£1,919GBP
- Report
- July 2024
- 164 Pages
Global
From €2243EUR$2,500USD£1,919GBP
- Report
- May 2024
- 134 Pages
Global
From €2690EUR$2,999USD£2,302GBP
€3588EUR$3,999USD£3,069GBP
- Report
- December 2023
- 221 Pages
Global
From €3229EUR$3,599USD£2,762GBP
- Report
- May 2025
- 134 Pages
Global
From €16143EUR$17,995USD£13,810GBP
- Report
- December 2024
- 59 Pages
Global
From €3584EUR$3,995USD£3,066GBP
- Report
- August 2026
- 160 Pages
From €2978EUR$3,320USD£2,548GBP
€3723EUR$4,150USD£3,185GBP
- Report
- August 2025
- 150 Pages
Global
From €2835EUR$3,160USD£2,425GBP
€3544EUR$3,950USD£3,031GBP
- Report
- July 2025
- 150 Pages
Global
From €4351EUR$4,850USD£3,722GBP
- Report
- March 2024
- 95 Pages
Europe
From €1346EUR$1,500USD£1,151GBP
- Report
- March 2024
- 97 Pages
Asia Pacific
From €1346EUR$1,500USD£1,151GBP
- Report
- March 2024
- 91 Pages
North America
From €1346EUR$1,500USD£1,151GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more